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The Relationship Between Blood Lead and
Blood Pressure in the NHANES 11 Survey
by Joel Schwartz*
A large body of experimental data has shown that lead raises blood pressure and increases
responsiveness to a-adrenergic agonists in rats and pigeons. These studies suggest the need to look
for a similar relationship in humans. This paper examines the robustness of the previously reported
association between blood lead and blood pressure in adult males. The association remains strong
and is essentially unchanged in tests that include nutritional factors and demographic factors, alone
or together, or in tests that include insignificant terms. The relationship was not confounded by age;
it held for all adult men in the 20-45 age group, the 40-59 age group, and the 46-74 age group.
Interaction terms for 25 30-year age groups (20-49, 21-50, . . . , 45-74) were all insignificant,
indicating no difference in the relationship by age. The relationship is also robust to the inclusion ofa
time trend to account for possible omitted time-varying factors, and it held in a model that controlled
for possible site effects. Given the strong experimental evidence, the relationship is likely causal.
Introduction
Recent experimental evidence has demonstrated that
moderate levels of lead cause elevations in blood
pressure in animals (1-6). These findings show effects
at varying doses and across species and indicate pos-
sible modes of action for lead that involve general
mechanisms operant across all animal species.
For instance, both Iannoconne et al. (1) and Car-
mignani et al. (2) have reported in vivo studies show-
ing that lead-exposed rats had increased response to a-
adrenergic stimulation. These results have been
reported in vitro by Webb et al. (4), using arteries from
rats that had been exposed in vivo. Such activity
would be expected to lead to increases in blood pressure.
Skoczynska et al. (7) also reported that lead-treated rats
had augmented and prolonged pressor responses to
epinephrine and norepinephrine, less pronounced
depression of arterial pressure in response to isopro-
terenol, and more pronounced tachycardia in response
to isoproterenol. Skoczynska et al. also found in perfu-
sion studies of isolated arteries that lead caused more
pronounced vasoconstriction in response to norepi-
nephrine.
Of particular interest, Piccinini and Favalli (8)
have reported that the addition of lead to the media of
perfused isolated rat tail arteries led to contraction and
to hyperreactivity in response to stimulation. The
exposed arteries had higher levels of cytosolic calcium
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than the control group, consistent with other findings
of lead causing a calcium leak into cells (9). Lead has
been found to contribute to increased intracellular
concentrations of calcium in brain capillaries (10),
neurons (11), osteoclasts (12), and hepatocytes (13). As
increased intracellular calcium is the trigger for
smooth muscle contraction, these results again suggest
a biological mechanism for an effect of low-level lead
exposure on blood pressure.
In addition, Goldstein and Ar (14) have reported
that lead activates calmodulin in its role of activating
phosphodiesterase, the enzyme that converts cyclic
AMP into AMP. Cyclic AMP is involved in stimu-
lating the calcium pump that removes calcium from
the cytosol into the endoplasmic reticulum and also
leads to the phosphorylation of myosin light-chain
kinase, reducing its sensitivity to activation by cal-
cium.These are actions thatwould be expected to reduce
reactivity and tone, and a lead effect on cyclic AMP
represents a potential adverse disturbance of these
processes.
Finally, the experimental literature suggests a
nonlinear relationship, with effects on blood pressure
primarily at the lower blood lead levels. Pounds (13)
reported that low-level exposure to lead caused in-
creased accumulation of calcium in all of the com-
partments of the cell, whereas at higher lead exposure,
the two shallower compartments, including the cyto-
sol, saturated out, and calcium accumulation con-
tinued only in the deepest compartment, thought to be
the mitochondria. Thus, the hypothesis that lead
increases blood pressure by disturbing cytosolic cal-J. SCHWAR7Z
cium metabolisms appears consistent with this non-
linearity in response.
In light of this finding of an effect and possible
mechanism, we examined a large representative sur-
vey of the U.S. population for a relationship between
blood lead and blood pressure. Some of these analyses
have previously been reported (15,16).
The Second National Health and Nutrition Exam-
ination Survey (NHANES II) was conducted between
February 1976 and February 1980 on a sample chosen
to be representative of the civilian, noninstitution-
alized U.S. population aged 6 months to 74 years. A total
of 20,322 persons were examined, and blood lead deter-
minations were obtained for a representative sub-
sample of 9932. The medical evaluations included
medical history, physical examination, anthropo-
metric measurements, dietary information (24-hr
recall and food frequency), laboratory tests, ECGs, and
radiographs. Special interview and examination pro-
tocols and specifically trained interviewers and exam-
iners were used to ensure standardized conduct of the
survey at each site. The nutrient intake from the 24-hr
recall was quantified for each individual using a
current nutrient data bank.
Blood samples were analyzed by the Clinical Chem-
istry Division, Centers for Disease Control. Blood lead
concentrations were determined by atomic absorption
spectrophotometry using a modified Delves Cup mi-
cromethod (17). Both bench and blind quality controls
were used.
The analysis of the relationship between blood lead
and blood pressure is confounded by age. Both lead and
blood pressure increase with age. Moreover, studies of
populations not exposed to the environment of western
civilization, both in Africa and the Pacific Islands, as
well as in isolated communities in Wales, show that
blood pressure does not increase with age. Thus, age
must be treated not as representing a marker for the
aging process, but rather as representing unknown
stresses, and the cumulative effect of elements of the
western environment. Lead is one of these elements,
and thus the confounding is real. To minimize that
confounding we have adopted several approaches.
First, we performed analyses in the 40- to 59-year-old
age group, the age group with the lowest correlation
between blood pressure and age. Second, we have
repeated the analyses for all men aged 20 to 74, with the
expectation that the large sample size will partly
mitigate the confounding. Finally, we have repeated
our analyses with interaction terms for different age
groups, to testforthe uniformity ofthe effect across ages
without paying the sample size penalty that sub-
sampling entails.
Initial Analysis
40- to 59-Year-Old Cohort
Tlhe established correlates of blood pressure are age,
sex, race, and obesity. We used Quetelets body mass
index (BMI) (weight/height2) as the principal obesity
measure in this analysis. For the 40- to 59-year-old age
group we only considered white males. We forced age
into the models in order to avoid any upward bias in
the lead coefficients.
The natural log of blood lead was more normally
distributed, more significant, and gave a higher R2
than untransformed blood lead, blood lead squared,
blood lead + blood lead squared, the square root ofblood
lead, or blood lead to other fractional powers (we
examined 0.15, 0.2, 0.3, and 0.4). All of the results
reported here are for the natural log of blood lead, but
regressions for untransformed lead gave very similar
results.
The initial regressions analyzed systolic and dias-
tolic blood pressure for white males, 40 to 59 years old,
with a model consisting of age, age squared, BMI, and
blood lead. These regressions were done to determine
whether blood lead levels were significantly associated
with systolic and diastolic blood pressure after
controlling for the well-documented correlates of blood
pressure. Lead was statistically significant (p < 0.01) for
both systolic and diastolic blood pressures in all OLS
(ordinary least squares) regressions, in weighted re-
gressions, and in weighted regressions with the
design effects ofthe survey.
Tests of Robustness
The regression models were then expanded to incor-
porate additional variables, with particular attention
directed to the stability and significance of the lead
coefficient in the presence of nutritional factors and
blood biochemistries.
A large set of nutritional and biochemical variables
from NHANES II was included in stepwise regres-
sions. The large set was used because blood pressure is
such a multifactorial outcome and because we desired
to test the robustness of the lead relationship to the
inclusion of other variables, and the reporting of sig-
nificance for any of them in these analyses should not
be taken as an endorsement of a relationship. In addi-
tion, a large set of demographic and personal history
variables was also considered in stepwise regressions.
Nutritional and Biochemical Variables
To provide an unusually rigorous test of the inde-
pendent significance of blood lead, almost all of the nu-
tritional and biochemical variables in the NHANES
II were included in stepwise regressions. In addition,
to account for possible curvilinear relationships,
squared and natural logarithmic transformations of
these variables were also included. The variables are
listed in Table 1. The objective was not to evaluate the
possible association of nutritional or biochemical
measurements with blood pressure, but rather to con-
servatively estimate the strength and independence of
the relationship between blood lead and blood pressure.
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Table 1. Variables included in the stepwise regression analysis.
Agea
Age2a
Body mass index
Dietary sodiumb
Salt-shaker sodium
Dietary sodium x
salt-shaker sodium
Dietary potassiumb
Dietary sodium-
potassium ratio
Dietarycalciumb
Dietary phosphorusb
Dietary proteinb
Dietary fatb
Dietary carbohydrateb
Dietary cholesterolb
Dietary saturated
fatty acidsb
Dietary oleic acidb
Dietary linoleic acidb
Dietary ironb
DietaryvitaminAb
Dietaryvitamin Cb
Dietarythiamineb
Dietary riboflavinb
Dietary niacinb
Serum cholesterolb
Serum vitamin Cb
Serum ironb
Serum transferrin saturation
Serum zincb
Serum copperb
Serum albuminb
Hemoglobinb
Red blood cell count
Ethanol consumption/weekb
Cigarettes smoked/day
Total dietarygramsb
Total dietary caloriesb
Cigar orpipe smoking
aForced into each regression to remove any possible age effects on
blood pressure.
1'Me natural log and squared transformation ofthese variables were
also included in the stepwise regression.
Including these additional 87 variables increases the
probability of variables being found statistically sig-
nificant due to chance alone. This complicates the in-
terpretation of nutritional and biochemical factors, but
not the interpretation of the lead variable; it only makes
it more difficult for lead to maintain its significance.
The general procedure for variable selection was as
follows: First, weighted, stepwise multiple linear
regression was used to determine which variables
were significantly related (p < 0.05) to blood pressure
(using the MAXR options of the SAS procedure
Stepwise). The MAXR procedure determines for any
given model size (i.e., number of independent vari-
ables) the variables that explain the greatest amount of
the variance of blood pressure. We chose the largest
model with all variables significantly related to blood
pressure (p < 0.05). From the 87 nutritional and bio-
chemical variables, the weighted, stepwise regression
selected 5 additional variables for diastolic pressure
and 6 additional variables for systolic pressure, using
the 5% significance test. These were used as the starting
model for the SAS procedure SURREGR, which in-
corporates the survey design effects. For both systolic
and diastolic blood pressures, one variable from the
weighted stepwise regression failed to maintain sig-
nificance at the 5% level after the design effects were
incorporated. The final regression results for systolic
and diastolic pressures, after accounting for the
weighting and design effects, are given in Table 2.
To investigate whether a threshold level, below
which no effect ofblood lead on blood pressure existed,
piecewise linear regressions were performed using the
SAS procedure NLIN. These segmented regressions fit
two lines to the data. One, below the putative blood lead
threshold T, depends on all the variables except lead.
The other, for blood lead levels above T, includes lead.
Table 2. Regression ofdiastolic and systolic blood pressures in
white males age 40 to 59.
Variable Coefficient t-Statistic Probability
Diastolic
Age 0.2768 0.17 0.8636
Age2 - 0.0014 0.10 0.9321
Body mass index 1.131 8.55 0.0001
Log(blood lead) 3.954 2.85 0.0080
Dietary potassium - 0.0018 4.92 0.0001
Hemoglobin 1.548 3.90 0.0005
Albumin 3.587 2.50 0.0179
Log(dietaryvitamin C) 1.838 4.65 0.0001
Systolic
Age 1.311 0.57 0.5720
Age2 - 0.0068 0.30 0.7706
Body mass index 1.736 9.42 0.0001
Log(blood lead) 8.436 3.24 0.0028
Albumin 7.088 2.50 0.0178
Log(dietaryvitamin C) 2.411 3.84 0.0005
Log(dietary riboflavin) - 5.509 3.07 0.0044
Log(dietary oleic acid) 3.992 2.49 0.0183
Log(serum vitamin C) - 3.472 2.47 0.0184
We used an iterative algorithm that chooses the
threshold point that minimizes the sum of the squares
ofthe errors overthe full range ofblood lead levels.
After including the nutritional variables, the blood
analytes, and their curvilinear transforms, blood lead
remained significantly associated (p < 0.05) with both
systolic and diastolic blood pressures. The coefficient of
lead in the regressions was within 10% of the original
value. Further, the segmented regression analysis
indicated that there was no threshold blood lead level
in the relationship.
Interaction Terms
In multiple regression analysis, another considera-
tion is the possibility of significant interaction terms.
To evaluate this possibility, an additional weighted,
stepwise regression analysis was done for both systolic
and diastolic blood pressure. The new variables
consisted of the linear interaction terms between the
final variables in the model (shown in Table 2) and the
linear form of all the other variables originally
considered for the initial stepwise regression (Table 1).
This meant running a stepwise regression with 162
interaction terms added to the final regression models
for systolic and diastolic blood pressures. Using such a
large set ofvariables gave a high probability that some
variables would enter at the 5% level by chance.
However, the purpose was not to determine if these
variables were independently significant, but rather to
further test the significance and independence of the
relationship between blood pressure and blood lead. As
expected, several interaction terms entered the systolic
and diastolic regressions, but in each regression the
lead coefficient varied less than 10% from its original
value and remained significant (p < 0.015).
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Marginally Insignificant Variables
Three other analyses were done to ensure that this
relationship was robust. First, the original weighted,
stepwise regression was extended to include variables
significant through the 15% level to see if marginally
insignificant variables influenced the significance of
lead. For both systolic and diastolic pressures, lead
remained significant and there was little change in
the magnitude ofthe coefficient (less than 10%).
Second, for diastolic blood pressure, all the variables
were included that were significant between the p =
0.05 and the p = 0.15 levels, and every possible com-
bination ofthose variables (taken 1, 2, 3, 4, 5, 6, 7, and 8
at a time) was considered. All 255 combinations were
added to the variables that were significant at the 5%
levels, and a regression was performed on each set. The
coefficient of blood lead varied by only +10% to -10%
from the value that we obtained when we only
included significant variables, and lead was always
significant (p < 0.01). This analysis was not repeated
for systolic blood pressure.
The last analysis was the most demanding test of the
independence of the relationship between blood pres-
sure and blood lead. Models for systolic and diastolic
blood pressure were fitbyweighted, stepwise regression
using the original candidate variables (Table 1) but
excluding lead. This gave all of the other variables and
their curvilinear transformations the maximum
opportunity to explain variation that could also be
explained by lead. After obtaining these new, final
models, a single regression for each outcome was run
adding the lead variable to the variables of this model.
For both systolic and diastolic blood pressures, lead was
still statistically significant (p < 0.016) and the mag-
nitude of the lead coefficient changed less than 10%
from those obtained in the original analyses.
Because some people have found that small amounts
of ethanol are associated with reduced blood pressure,
ethanol was also modeled as a quadratic function of
alcohol consumption, and also with two dummy var-
iables for low and high consumption. The stepwise re-
gression was repeated, and results did not change. The
results of these analyses indicate that the strength and
independence of the relationship between blood lead
pressure was remarkably stable.
Demographic and Personal History
Variables
We next considered the possibility that inclusion of
the variables shown in Table 3 would affect the stability
of the lead regression. Hypertension medication and
low salt dietwere tested to see ifthe response to lead was
altered by these factors. The inclusion of these factors
and interaction terms between them and lead did not
change the lead coefficient appreciably, and the
interaction terms were insignificant. As hypertension
medication is a marker for high blood pressure, its
Table 3. Nonnutrilion variables tested in the stepwise regression.
Variables Other personalhistoryvariables
Demographic Triceptskinfold
Family income Subscapular skinfold
Poverty index Recreational exercise
Region ofthe country Work-related exercise
Season oftheyear Recentweightloss
Degree ofurbanization Family history ofhypertension
Residence inside central city Kidney disease
Educational level Serum creatinine
Hypertension
Hypertensive medication
Low salt diet
inclusion in a model is not very informative. All of the
subsequent analyses were performed with and with-
out the inclusion of hypertension medication.
The other variables in Table 3 were tested in two
ways. First, the stepwise regression procedure was
repeated using the variables in Table 3 and only the
nutritional and biochemical variables that had been
significant at the 15% level in the previous analysis.
Again, lead was selected for both systolic and diastolic
blood pressure (p < 0.005) and its coefficient was within
10% of the original model that contained only age,
age2 and body mass index.
The variables in Table 3 were then added to all of
those in Table 1, including their curvilinear trans-
forms, and the stepwise process was repeated, yielding
the same results. Finally, we re-ran the stepwise
regression using all of the variables in Tables 1 and 3
except for lead, allowing maximum opportunity for
colinear factors to enter. Lead was then inserted in the
resulting models for systolic and diastolic blood pres-
sure. It was still significant (p < 0.01) with less than a
10% change in its coefficient. In addition, smoking
and drinking were forced into the regression models,
and lead remained significant (p < 0.01), with no
noticeable change in its coefficient.
Previous analyses have shown that about half of the
lead in people in the NHANES II sample came from
gasoline (18,19). Tetraethyl lead has little cadmium
contamination, so confounding with cadmium is
unlikely. However, occupationally exposed workers are
also exposed to cadmium, so we repeated the regression
excluding all persons in job categories cited by NIOSH
as having potential lead exposure. Lead remained
significant for both systolic and diastolic blood
pressure (p < 0.01).
Principal Components Analyses
Because nutritional variables are often colinear with
each other and may in fact only be important in
complexes, a second approach was taken to dealing with
nutritional and serological variables. Principal com-
ponents analysis was done to find the linear combina-
tions of the nutritional and serological factors that
explained the greatest amount of their common vari-
18BLOOD LEADAND BLOOD PRESSURE
ation. These principal components were then entered
into the stepwise regression to allow those factors to
explain a greater amount of the variation in blood
pressure before colinearity prevents any more vari-
ables from entering. For instance, the first five prin-
cipal components ofthe variables in Table 1 explain 50%
of their variation. When these principal components
were used instead of the raw variables and the stepwise
regression was repeated, lead again was significantly
associated with both systolic and diastolic blood
pressure (p < 0.01), and its coefficient was changed by
less than 10% from its original value.
Colinearity and Influence Diagnostics
Although all of these analyses make it clear that
colinearity is not the cause of lead's correlation with
blood pressure, variance inflation factors were
computed for our final models. No significant variable
had a variance inflation factor above 1.4.
To ensure that the significance of lead in the regres-
sion was not due to the presence of a few influential
observations, influence diagnostic procedures were
run. Residuals were plotted for all the observations,
and the largest residuals were clustered near the mid-
dle of the data, where their influence is slight. Cook's D
statistics, a standard measure of an observation's in-
fluence on a regression, were also computed for each
observation. The highest Cook's D was 0.029 and the
second highest was 0.023, both of which are very small.
Moreover, ofthe 10 observations with the largest Cook's
D statistics, 6 had positive residuals and 4 had negative
residuals, indicating that the most influential obser-
vation's split almost evenly on how they would influ-
ence the lead coefficient. Figures 1 and 2 show the
relationship between blood lead and both systolic and
diastolic blood pressure in this population, after ad-
justing for all of the other significant covariates.
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FIGURE 1. Adjusted diastolic blood pressure and adjusted blood lead
levels for white males age 40 to 59. Both blood pressure and blood
lead have been adjusted by regression for the effects of age, age2,
body mass, and other significant variables listed in Tables 2 and 3.
Each point represents the mean blood pressure and mean blood
lead for 24 consecutive observations, sorted in increasing order of
blood lead.
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FIGURE 2. Adjusted systolic blood pressure and adjusted blood lead
levels for white males age 40 to 59. Both blood pressure and blood
lead have been adjusted by regression for the effects of age, age2,
body mass, and other significant variables listed in Tables 2 and 3.
Each point represents the mean blood pressure and mean blood
lead for 24 consecutive observations, sorted in increasing order of
blood lead.
Results for All Adult Men
The 40- to 59-year-old age group represents about one-
third of adult males and is the only group where the
confounding of age and blood lead can be eliminated
unambiguously. Additional regressions were per-
formed, however, to confirm the relationship in the
full population of adult men (> 20 years of age). Again,
our analysis began by looking at the basic variables
clearly linked to blood pressure: age, race, and body
mass. Age was again modeled with both a linear and
quadratic term to account for the nonlinear depen-
dence. In this analysis, blacks were included, and a
dummy variable for race was included in the regres-
sion because the sample size was now large enough to
permit separating the race effect. Lead was once more
found to be a significant predictor of both systolic and
diastolic blood pressure (p < 0.01).
Tests of Robustness
We next included all of the variables in Table 1 and
Table 3, along with their square and log transforms, in
a stepwise regression analysis, to test whether
inclusion of these other variables could affect the lead-
blood pressure relationship. Lead was selected as sig-
nificant for both systolic and diastolic blood pressure
(p < 0.01). This result held whether or not hypertensive
medication was included in the stepwise regression.
Figures 3 and 4 show the relationship between blood
lead and both systolic and diastolic blood pressure in
all adult men after controlling for all covariates.
To assure that lead was not acting for a variable that
did not enter the regression because it was colinear
with lead, we re-ran the stepwise regression using all of
the variables in Tables 1 and 3 except for lead. Lead was
then inserted in the resulting model and its sig-
nificance checked. Lead was significantly related to
both systolic and diastolic blood pressure (p < 0.01).
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levels for males age 20 to 74. Both blood pressure and blood lead
have been adjusted by regression for the effects of age, age2, body
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point represents the mean blood pressure and mean blood lead for
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FIGURE 4. Adjusted systolic blood pressure and adjusted blood lead
levels for males age 20 to 74. Both blood pressure and blood lead
have been adjusted by regression for the effects of age, age2, body
mass, and other significant variables listed in Tables 2 and 3. Each
point represents the mean blood pressure and mean blood lead for
24 consecutive observations, sorted in increasing order of blood
lead.
Interactions with Hypertension or
Hypertensive Medication
To assure that a spurious correlation was not occur-
ring due to an interaction of lead levels with hyper-
tensive medication or due to kidney disease elevating
both blood pressure and blood lead levels, several addi-
tional analyses were performed. The stepwise regres-
sions were repeated excluding all persons on hyper-
tensive medication. Again, all variables in Table 1 were
considered, not to determine whether they were true
predictors of blood pressure, but to allow maximum
possibility for another factor to explain the correlation
between blood pressure and lead. Lead was signifi-
cantly related to both systolic and diastolic blood pres-
sure (p < 0.01). Serum creatinine was forced into the
regression, and lead remained significant (p < 0.01).
Next, the stepwise regression was repeated including
hypertensive medication as a variable. Lead was again
selected for both systolic and diastolic blood pressure
(p < 0.01), and an interaction term between lead and
hypertensive medication was not significant. Finally,
all men with diastolic blood pressure above 90 mm Hg
were excluded from the sample, and the stepwise
regression was repeated. Lead was again chosen as sig-
nificantly related to both systolic and diastolic blood
pressure (p < 0.01).
Other Age Groups
The most robust way to check for a differential lead
effect in different age groups is to use interaction terms,
thereby maintaining sample size. We used dummy
variables for the age groups 20 to 39 and 60 to 74 and
interaction terms between them and lead. The inter-
action terms were highly insignificant (p > 0.35),
indicating the same magnitude effect in all ages.
As a further check, we separately ran the stepwise
regression, using all of the variables in Tables 1 and 3,
for the age groups 20 to 45 and 45 to 74. The larger age
groups were used to compensate for the increased
colinearity with age. Lead was chosen as significant
for both age groups, forboth systolic and diastolic blood
pressure. Next, the regression for all adult males was
repeated, but an interaction term for the 25 sequential
age groups (20-49, 21-50, . . . ,45-74) was tested in 50
separate regressions (one for each age group, for both
diastolic and systolic blood pressure). Lead was sig-
nificant in each regression, and the interaction term
was insignificant, again indicating a uniform rela-
tionship in all age groups. Finally, the regressions for
both systolic and diastolic blood pressure were repeated
in each of the 25 age groups, and lead was significant
in all 50 regressions. Figure 5 shows the coefficients of
diastolic blood pressure plotted against the median age
for each of the 25 subgroups. The slope appears lower,
although insignificantly so, in the youngest age
groups. For the remaining 20 age groups, the slope
oscillates about a mean of approximately 3.4 (on the log
scale), indicating that a drop in blood lead levels from
18 ,ug/dL to 10 ,ug/dL would reduce diastolic blood
pressure by 2 mm Hg.
Time Trends
The introduction of unleaded gasoline in 1975
created a time trend in blood lead levels in the United
States. This downward trend accelerated in 1978 when
further regulations restricted the amount of lead in
leaded gasoline. Since the NHANES II blood lead data
was collected from February 1976 to February 1980,
there is a time trend in the blood lead data. Ifthere were
a time trend in blood pressure because ofanotherfactor,
and that factor were omitted from the analysis, this
would confound the relationship. Examination of the
blood pressure levels in the National Health Survey in
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the 1960s, in the NHANES I from 1971 to 1975, and in
the NHANES II, show that levels in NHANES II were
the same as in the 1960s but somewhat lower than in
NHANES I. Thus, no clear trend in blood pressure over
time is evident. The data are qualitatively suggestive of
the relationship we have found within the NHANES II
survey, since gasoline lead use peaked during the
period of the NHANES I survey. Nevertheless, it is im-
portant to make sure that the relationship we have
identified is not confounded.
Other Covariates That Might Change Over
Time. Time trends in other causal factors of blood
pressure will only confound the analysis if those
factors are omitted, and the first approach is to include
them. Obesity, exercise, diet, serum cholesterol levels,
smoking, etc., are all included in the model; changes in
these factors will not confound the lead relationship.
The dietary variables are sensitive enough to measure,
e.g., changes in saturated versus polyunsaturated fats
in the diet. Increased use of hypertensive medication
over time was similarly controlled for, and in fact, no
major external determinant of blood pressure has been
omitted from the analysis, making confounding
unlikely.
Modeling Time Trend. Because blood lead levels
fell at a much faster rate in the last 2 years of the
NHANES II survey, the slope ofthe correlation between
blood lead and an omitted time-dependent covariate
would have changed in the second half of the survey. If
the correlation between blood lead and blood pressure
was due to blood lead correlating with this omitted
covariate because both of them have a time trend, then
the slope of the blood lead-blood pressure relationship
would also change in the second half. We tested this by
entering an interaction term in our model. The inter-
action term was highly insignificant (p = 0.75 systolic,
p = 0.79 diastolic), indicating that the major change in
the decline ofblood lead over time was not accompanied
by any change in the relationship with blood pressure.
Next, we inserted a term for time into our model for
all adult men and re-estimated. Lead was again sig-
nificant as a predictor of both systolic and diastolic
blood pressure (p < 0.05). We concluded that an omitted
time trend is not confounding this analysis.
Geographical Variation
Since the survey took data in 64 locations, it is pos-
sible that there are design effects in the data. The
SURREGR regression package that we used accounts
for the design effects by estimating the covariance
using a Taylor series approximation for the off-
diagonal effects. An alternative is to assume a different
intercept for each sampling unit. This also examines
the time trend issue in a different way. As the sites were
sampled at different times, the different site intercepts
represent either site or time differences. As the 64 PSUs
were randomly selected from candidate PSUs to
represent the U. S. population, we have used a random
effects model (20). Using this model to include site
effects, we found that lead was still a significant
predictor of both systolic and diastolic blood pressure
(p < 0.05) for both all adult males and the 40- to 59-year-
old age group. The regression coefficients are reduced
about 25% in these models. We conclude that the
relationship is not confounded by either site or time
effects.
Conclusions
There is a robust relationship between low-level lead
exposure and blood pressure in the NHANES II data.
This relationship holds whether we only examine the
age group with minimal age confounding or whether
we examine all adult men. It is not confounded by any
plausible dietary, demographic, or apthropometric
variables. It holds after controlling for the time trend
in the data and may be the cause ofthat trend.
The animal evidence clearly indicates a causal rela-
tionship between lead exposure and blood pressure in
several species. The animal data also show that lead
interferes with cellular calcium metabolism in ways
thatwould be expected to increase blood pressure; these
mechanisms also regulate blood pressure in humans.
Essentially all of the recent human studies have
found a positive association between blood lead and
blood pressure. In most of the studies the association
has been significant, in some of the others the mag-
nitude of the insignificant association was similar to
the magnitude in the significant findings. Although
most of the studies have been in men, recently Rab-
inowitz et al. (21) have reported that umbilical cord
blood lead was significantly associated with both blood
pressure at delivery and the presence of pregnancy
hypertension in a sample of 3200 live births in Boston
with low lead levels (mean blood lead = 6.9 ,ug/dL).
Given these results and the strength of the animal
models, the conclusion that there is a causal association
seems warranted.
Small changes in blood pressure, even at levels below
those defined as hypertension, were associated with
0
0 0 0
0 0
0 0
0 0 0 0
0 0 0
0
0
0 0 0
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increased risk ofheart attacks, strokes, and deaths in the
Framingham study (22). While studies such as these
can only inferentially implicate lead in these serious
outcomes, the likelihood that lowering blood pressure
reduces those risks is considered high enough to
warrant giving drugs with serious side effects to per-
sons with diastolic blood pressure above 90 mm Hg. It
seems prudent to also recommend that reduction in
exposure to a toxic substance that raises blood pressure
is also warranted. Moreover, while these data do not
allow a direct assessment of the effect of lead on car-
diovascular deaths, there are two recent studies that
addressed that issue. Khera et al. (23) found signi-
ficantly higher levels of blood and urine lead in
hospital outpatients being treated for hypertension or
cardiovascular disease than in controls. Voors et al.
(24) found a highly significant association between
lead levels in the aorta ofan autopsy series and whether
the patient had died of cardiovascular disease. Again, it
seems likely that measures to reduce lead exposure in
the U. S. population will lead to small, but important,
reductions in cardiovascular risk.
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